09:39am Friday 21 February 2020

Heart Attack Patients Winning the Race to Angioplasty Treatment

Published in Circulation: Journal of American Heart Association, the five-year study is one of the most comprehensive analyses of angioplasty timeliness. The period from hospital arrival to angioplasty is called “door-to-balloon” time (D2B). For patients with ST-segment elevation myocardial infarction (STEMI), angioplasty should be performed as quickly as possible within the recommended 90 minutes from hospital arrival.

Lead author Harlan M. Krumholz, M.D., and his colleagues analyzed nationwide hospital data, collected by the Centers for Medicare & Medicaid Services, from more than 300,00 patients undergoing emergency angioplasty Jan. 1, 2005, to Sept. 30, 2010, including those not covered by Medicare.

The study showed that 91 percent of patients were treated in a D2B time of less than 90 minutes in 2010, compared with 44 percent in 2005. Seventy percent of these patients were treated in less than 75 minutes in 2010, compared with 27 percent in 2005. The median D2B time declined from 96 to 64 minutes over the course of the study.

Krumholz credited the recent progress to concerted efforts nationwide among federal agencies, healthcare organizations and clinicians to improve heart attack care and outcome by accelerating treatment.

Krumholz, Elizabeth H. Bradley and others at Yale conducted NIH-funded studies that led to papers that served as the basis of the American College of Cardiology’s national campaign, the D2B Alliance, to reduce D2B times. The D2B Alliance involved more than 1,000 U.S. hospitals and sought to support the adoption of the research findings.

“Many said that this level of improvement was impossible to achieve,” Krumholz said. “This is an opportunity to reflect on our achievement and to recognize that, when we identify quality issues and problems in our healthcare system, we can work as a community to generate new knowledge, apply it to practice and improve care for patients.”

Other co-authors on the study include Bradley, Chris Granger, M.D., Jeph Herrin, Lauren E. Miller, Elizabeth E. Drye, M.D., Shari M. Ling, M.D., Lein F. Han, Michael T. Rapp, M.D., and Jeptha P. Curtis, M.D.

The Centers for Medicare & Medicaid Services and the National Heart, Lung and Blood institute funded the study. The work was also funded, in part, by the Yale Clinical and Translational Science Award (CTSA) grant from the National Center for Research Resources at the National Institutes of Health.

Citation: Circulation DOI: 10.1161/CirculationHA.111.044107

By Karen N. Peart


PRESS CONTACT: Karen N. Peart 203-432-1326

Share on:

MORE FROM Blood, Heart and Circulation

Health news